Literature DB >> 7782062

Peripheral and intracerebroventricular administration of human chorionic gonadotropin alters several hippocampus-associated behaviors in cycling female rats.

H Lukacs1, E S Hiatt, Z M Lei, C V Rao.   

Abstract

Our recent demonstration of receptors for luteinizing hormone (LH)/human chorionic gonadotropin (hCG) in rat brain with the highest density within the hippocampus and dentate gyrus suggests novel functional roles for gonadotropic hormones within the brain. The present study investigated whether 125I-hCG can cross the blood-brain barrier and reach hippocampus and the possible role of hCG in the regulation of several behavioral activities associated with the hippocampal formation in the rat. About 1/100th of peripherally injected 125I-hCG crossed the blood-brain barrier in an intact form and was found in cerebrospinal fluid and in hippocampus. Intraperitoneal (IP) or intracerebroventricular (ICV) injections of highly purified hCG on the morning of proestrus of cycling female rats resulted in changes in several hippocampus-associated behaviors. hCG-treated animals were generally less active and showed less exploratory behavior as compared to saline-injected control animals. There was no difference, however, in latency to enter the open field between hCG-treated and control animals. Taste neophobia was dramatically decreased following IP as well as ICV injection of hCG. No differences were found in the memory component of T-maze performance; however, the hCG-treated rats exhibited decreased stereotypic behavior. In summary, hCG can cross the blood-brain barrier, and peripheral or central administration of hCG affects several hippocampus-associated behaviors suggesting that hippocampal LH/hCG receptors are most likely involved in mediating these effects. Some of the observed behavioral changes have parallels in pregnant women.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7782062     DOI: 10.1006/hbeh.1995.1004

Source DB:  PubMed          Journal:  Horm Behav        ISSN: 0018-506X            Impact factor:   3.587


  29 in total

Review 1.  The role of gonadotropins in Alzheimer's disease: potential neurodegenerative mechanisms.

Authors:  Anna M Barron; Giuseppe Verdile; Ralph N Martins
Journal:  Endocrine       Date:  2006-04       Impact factor: 3.633

2.  Chronic treatment with estrogen receptor agonists restores acquisition of a spatial learning task in young ovariectomized rats.

Authors:  R Hammond; R Mauk; D Ninaci; D Nelson; R B Gibbs
Journal:  Horm Behav       Date:  2009-06-25       Impact factor: 3.587

Review 3.  Luteinizing hormone: Evidence for direct action in the CNS.

Authors:  Jeffrey A Blair; Sabina Bhatta; Henry McGee; Gemma Casadesus
Journal:  Horm Behav       Date:  2015-07-12       Impact factor: 3.587

4.  CNS luteinizing hormone receptor activation rescues ovariectomy-related loss of spatial memory and neuronal plasticity.

Authors:  Jeffrey A Blair; Sabina Bhatta; Gemma Casadesus
Journal:  Neurobiol Aging       Date:  2019-02-13       Impact factor: 4.673

5.  An update on the cognitive impact of clinically-used hormone therapies in the female rat: models, mazes, and mechanisms.

Authors:  J I Acosta; R Hiroi; B W Camp; J S Talboom; H A Bimonte-Nelson
Journal:  Brain Res       Date:  2013-01-16       Impact factor: 3.252

6.  Down-regulation of serum gonadotropins but not estrogen replacement improves cognition in aged-ovariectomized 3xTg AD female mice.

Authors:  Russell Palm; Jaewon Chang; Jeffrey Blair; Yoelvis Garcia-Mesa; Hyoung-Gon Lee; Rudy J Castellani; Mark A Smith; Xiongwei Zhu; Gemma Casadesus
Journal:  J Neurochem       Date:  2014-04-02       Impact factor: 5.372

7.  The beta-hCG+erythropoietin in acute stroke (BETAS) study: a 3-center, single-dose, open-label, noncontrolled, phase IIa safety trial.

Authors:  Steven C Cramer; Camille Fitzpatrick; Michael Warren; Michael D Hill; David Brown; Laura Whitaker; Karla J Ryckborst; Lawrence Plon
Journal:  Stroke       Date:  2010-03-04       Impact factor: 7.914

8.  Luteinizing hormone downregulation but not estrogen replacement improves ovariectomy-associated cognition and spine density loss independently of treatment onset timing.

Authors:  Jeffrey A Blair; Russell Palm; Jaewon Chang; Henry McGee; Xiongwei Zhu; Xinglong Wang; Gemma Casadesus
Journal:  Horm Behav       Date:  2015-10-21       Impact factor: 3.587

9.  Down-regulation of serum gonadotropins is as effective as estrogen replacement at improving menopause-associated cognitive deficits.

Authors:  Kathryn J Bryan; Joseph C Mudd; Sandy L Richardson; Jaewon Chang; Hyoung-Gon Lee; Xiongwei Zhu; Mark A Smith; Gemma Casadesus
Journal:  J Neurochem       Date:  2009-11-24       Impact factor: 5.372

10.  Direct action of gonadotropin in brain integrates behavioral and reproductive functions.

Authors:  Eun-Jin Yang; Brian T Nasipak; Darcy B Kelley
Journal:  Proc Natl Acad Sci U S A       Date:  2007-02-06       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.